P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS
Gespeichert in:
| Autor*in: |
Susser, S. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2014 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of the antigenic region of - Abdelbaky, Hanan H. ELSEVIER, 2018, official journal of the European Association for the Study of the Liver, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:60 ; year:2014 ; number:1 ; pages:487 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0168-8278(14)61359-3 |
|---|
| Katalog-ID: |
ELV012089885 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012089885 | ||
| 003 | DE-627 | ||
| 005 | 20230623094239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0168-8278(14)61359-3 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014005000030.pica |
| 035 | |a (DE-627)ELV012089885 | ||
| 035 | |a (ELSEVIER)S0168-8278(14)61359-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.44 |2 bkl | ||
| 100 | 1 | |a Susser, S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| 264 | 1 | |c 2014 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Flinders, M. |4 oth | |
| 700 | 1 | |a Reesink, H.W. |4 oth | |
| 700 | 1 | |a Zeuzem, S. |4 oth | |
| 700 | 1 | |a Lawyer, G. |4 oth | |
| 700 | 1 | |a Ghys, A. |4 oth | |
| 700 | 1 | |a Van Eygen, V. |4 oth | |
| 700 | 1 | |a Witek, J. |4 oth | |
| 700 | 1 | |a De Meyer, S. |4 oth | |
| 700 | 1 | |a Sarrazin, C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Abdelbaky, Hanan H. ELSEVIER |t Identification of the antigenic region of |d 2018 |d official journal of the European Association for the Study of the Liver |g Amsterdam [u.a.] |w (DE-627)ELV000433829 |
| 773 | 1 | 8 | |g volume:60 |g year:2014 |g number:1 |g pages:487 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0168-8278(14)61359-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.44 |j Parasitologie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 60 |j 2014 |e 1 |h 487 |y 60.2014, 1, S487- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s s ss |
|---|---|
| matchkey_str |
sussersflindersmreesinkhwzeuzemslawyergg:2014----:19rtetetihearvraetilteayfetlpeiepsripaesuisepeunenl |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.44 |
| publishDate |
2014 |
| allfields |
10.1016/S0168-8278(14)61359-3 doi GBVA2014005000030.pica (DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 DE-627 ger DE-627 rakwb 610 610 DE-600 610 VZ 44.44 bkl Susser, S. verfasserin aut P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Flinders, M. oth Reesink, H.W. oth Zeuzem, S. oth Lawyer, G. oth Ghys, A. oth Van Eygen, V. oth Witek, J. oth De Meyer, S. oth Sarrazin, C. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:60 year:2014 number:1 pages:487 https://doi.org/10.1016/S0168-8278(14)61359-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 60 2014 1 487 60.2014, 1, S487- 045F 610 |
| spelling |
10.1016/S0168-8278(14)61359-3 doi GBVA2014005000030.pica (DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 DE-627 ger DE-627 rakwb 610 610 DE-600 610 VZ 44.44 bkl Susser, S. verfasserin aut P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Flinders, M. oth Reesink, H.W. oth Zeuzem, S. oth Lawyer, G. oth Ghys, A. oth Van Eygen, V. oth Witek, J. oth De Meyer, S. oth Sarrazin, C. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:60 year:2014 number:1 pages:487 https://doi.org/10.1016/S0168-8278(14)61359-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 60 2014 1 487 60.2014, 1, S487- 045F 610 |
| allfields_unstemmed |
10.1016/S0168-8278(14)61359-3 doi GBVA2014005000030.pica (DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 DE-627 ger DE-627 rakwb 610 610 DE-600 610 VZ 44.44 bkl Susser, S. verfasserin aut P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Flinders, M. oth Reesink, H.W. oth Zeuzem, S. oth Lawyer, G. oth Ghys, A. oth Van Eygen, V. oth Witek, J. oth De Meyer, S. oth Sarrazin, C. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:60 year:2014 number:1 pages:487 https://doi.org/10.1016/S0168-8278(14)61359-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 60 2014 1 487 60.2014, 1, S487- 045F 610 |
| allfieldsGer |
10.1016/S0168-8278(14)61359-3 doi GBVA2014005000030.pica (DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 DE-627 ger DE-627 rakwb 610 610 DE-600 610 VZ 44.44 bkl Susser, S. verfasserin aut P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Flinders, M. oth Reesink, H.W. oth Zeuzem, S. oth Lawyer, G. oth Ghys, A. oth Van Eygen, V. oth Witek, J. oth De Meyer, S. oth Sarrazin, C. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:60 year:2014 number:1 pages:487 https://doi.org/10.1016/S0168-8278(14)61359-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 60 2014 1 487 60.2014, 1, S487- 045F 610 |
| allfieldsSound |
10.1016/S0168-8278(14)61359-3 doi GBVA2014005000030.pica (DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 DE-627 ger DE-627 rakwb 610 610 DE-600 610 VZ 44.44 bkl Susser, S. verfasserin aut P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Flinders, M. oth Reesink, H.W. oth Zeuzem, S. oth Lawyer, G. oth Ghys, A. oth Van Eygen, V. oth Witek, J. oth De Meyer, S. oth Sarrazin, C. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:60 year:2014 number:1 pages:487 https://doi.org/10.1016/S0168-8278(14)61359-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 60 2014 1 487 60.2014, 1, S487- 045F 610 |
| source |
Enthalten in Identification of the antigenic region of Amsterdam [u.a.] volume:60 year:2014 number:1 pages:487 |
| sourceStr |
Enthalten in Identification of the antigenic region of Amsterdam [u.a.] volume:60 year:2014 number:1 pages:487 |
| format_phy_str_mv |
Article |
| bklname |
Parasitologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Identification of the antigenic region of |
| authorswithroles_txt_mv |
Susser, S. @@aut@@ Flinders, M. @@oth@@ Reesink, H.W. @@oth@@ Zeuzem, S. @@oth@@ Lawyer, G. @@oth@@ Ghys, A. @@oth@@ Van Eygen, V. @@oth@@ Witek, J. @@oth@@ De Meyer, S. @@oth@@ Sarrazin, C. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000433829 |
| dewey-sort |
3610 |
| id |
ELV012089885 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012089885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623094239.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0168-8278(14)61359-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014005000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012089885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0168-8278(14)61359-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Susser, S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flinders, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reesink, H.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zeuzem, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawyer, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghys, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Eygen, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Witek, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Meyer, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarrazin, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdelbaky, Hanan H. ELSEVIER</subfield><subfield code="t">Identification of the antigenic region of</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the European Association for the Study of the Liver</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000433829</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:487</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0168-8278(14)61359-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">487</subfield><subfield code="y">60.2014, 1, S487-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Susser, S. |
| spellingShingle |
Susser, S. ddc 610 bkl 44.44 P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| authorStr |
Susser, S. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000433829 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.44 bkl P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| topic |
ddc 610 bkl 44.44 |
| topic_unstemmed |
ddc 610 bkl 44.44 |
| topic_browse |
ddc 610 bkl 44.44 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m f mf h r hr s z sz g l gl a g ag e v v ev evv j w jw m s d ms msd c s cs |
| hierarchy_parent_title |
Identification of the antigenic region of |
| hierarchy_parent_id |
ELV000433829 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Identification of the antigenic region of |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000433829 |
| title |
P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| ctrlnum |
(DE-627)ELV012089885 (ELSEVIER)S0168-8278(14)61359-3 |
| title_full |
P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| author_sort |
Susser, S. |
| journal |
Identification of the antigenic region of |
| journalStr |
Identification of the antigenic region of |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
487 |
| author_browse |
Susser, S. |
| container_volume |
60 |
| class |
610 610 DE-600 610 VZ 44.44 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Susser, S. |
| doi_str_mv |
10.1016/S0168-8278(14)61359-3 |
| dewey-full |
610 |
| title_sort |
p1199 re-treatment with telaprevir-based triple therapy after telaprevir exposure in phase 1 studies: deep sequence analysis for persistence of resistant variants |
| title_auth |
P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS |
| url |
https://doi.org/10.1016/S0168-8278(14)61359-3 |
| remote_bool |
true |
| author2 |
Flinders, M. Reesink, H.W. Zeuzem, S. Lawyer, G. Ghys, A. Van Eygen, V. Witek, J. De Meyer, S. Sarrazin, C. |
| author2Str |
Flinders, M. Reesink, H.W. Zeuzem, S. Lawyer, G. Ghys, A. Van Eygen, V. Witek, J. De Meyer, S. Sarrazin, C. |
| ppnlink |
ELV000433829 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0168-8278(14)61359-3 |
| up_date |
2024-07-06T21:27:45.472Z |
| _version_ |
1803866619744616448 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012089885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623094239.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0168-8278(14)61359-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014005000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012089885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0168-8278(14)61359-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Susser, S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flinders, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reesink, H.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zeuzem, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawyer, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghys, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Eygen, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Witek, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Meyer, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarrazin, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdelbaky, Hanan H. ELSEVIER</subfield><subfield code="t">Identification of the antigenic region of</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the European Association for the Study of the Liver</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000433829</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:487</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0168-8278(14)61359-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">487</subfield><subfield code="y">60.2014, 1, S487-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401575 |